Today is a great day for all of us. The licensing of the ChAdOx vaccine will mean a step change in vaccine deployment and is one of the most significant developments of the year. As is widely known, the vaccine developed is cheap, easy to store and we have enough doses to meaningfully start talking about widespread programmes of vaccination.
Already a subscriber? Log in
Get 10 issues
for $10
Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $10.
- Delivery of the weekly magazine
- Unlimited access to spectator.com.au and app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in